Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study

Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

(2010) Philip W. Kantoff et al.   JOURNAL OF CLINICAL ONCOLOGY

Quantitative DNA Methylation Analysis of FOXP3 as a New Method for Counting Regulatory T Cells in Peripheral Blood and Solid Tissue

(2009) G. Wieczorek et al.   CANCER RESEARCH

Therapeutic Vaccination with an Interleukin-2–Interferon-γ-Secreting Allogeneic Tumor Vaccine in Patients with Progressive Castration-Resistant Prostate Cancer: A Phase I/II Trial

(2009) Thomas H. Brill et al.   HUMAN GENE THERAPY

Phase 1 Trial of Allogeneic Gene-Modified Tumor Cell Vaccine RCC-26/CD80/IL-2 in Patients with Metastatic Renal Cell Carcinoma

(2009) Alexander Buchner et al.   HUMAN GENE THERAPY

Revisiting the Prognostic Value of Regulatory T Cells in Patients With Cancer

(2009) Cecile Badoual et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Trial of B7-1 (CD-86) Transduced, Cultured Autologous Tumor Cell Vaccine Plus Subcutaneous Interleukin-2 for Treatment of Stage IV Renal Cell Carcinoma

(2009) Mayer Fishman et al.   JOURNAL OF IMMUNOTHERAPY

Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines

(2008) Tanja D. de Gruijl et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Randomized clinical studies of anti-tumor vaccination: state of the art in 2008

(2008) Philippe Fournier et al.   Expert Review of Vaccines

Suppressive Influences in the Immune Response to Cancer

(2008) Vincenzo Bronte et al.   JOURNAL OF IMMUNOTHERAPY